Published trade mark details for 2090137

This information was published on 2020-05-21T02:03:16 for IP Right Filed Published.

Field	Value
(210)	2090137 (IR 1532183)
(220)	10 Mar 2020
(300)	US, 05 Mar 2020, 88822744
(500)	The mark consists of the word REBLOZYL in purple with three pink and purple dots to the right of the word. Purple and pink. The word REBLOZYL in purple with three pink and purple dots to the right of the word.
(511) (510)	Class 5 Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.
(540)
(550)	Figurative
(730)	Celgene Corporation

 

Find out more about publications on the About page.